
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded suppository containing hydroxyzine hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing hydroxyzine are listed in tablet, capsule, solution, injection and syrup forms. No finished hydroxyzine product of any kind is listed in suppository form.
Suppository bases differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Hydroxyzine is a first-generation antihistamine with calming and anti-itch effects that compounding pharmacies prepare in oral forms by prescription.
Hydroxyzine is a first-generation antihistamine of the piperazine class. It blocks histamine, the chemical behind allergic itching, and also quiets activity in parts of the brain below the cortex, which is why it causes drowsiness and eases tension. It was approved in the United States in 1957. Manufactured hydroxyzine hydrochloride tablets and syrup, hydroxyzine pamoate capsules (Vistaril) and a hydroxyzine injection are prescription products. The oral labels list symptomatic relief of anxiety and tension, itching from allergic conditions such as chronic hives and atopic or contact dermatitis, and use as a sedative before and after general anesthesia. A prescriber might order it compounded as a liquid in a strength or flavor not made commercially, in a dye-free vehicle, or as a capsule for someone who cannot take the manufactured form. Compounded preparations are not FDA-approved and require a prescription.
Hydroxyzine has no boxed warning. Do not take it if you have a prolonged QT interval, if you are allergic to hydroxyzine, cetirizine or levocetirizine, or in early pregnancy, where the label calls it contraindicated. QT prolongation and a dangerous rhythm called torsade de pointes have been reported, mostly in people with heart disease, low electrolytes or other QT-prolonging drugs. It adds to alcohol and other sedatives. It causes drowsiness, so do not drive until you know how it affects you, and older adults may become confused. Stop it and call your prescriber at the first sign of rash, which can signal a rare pustular reaction (AGEP). The label says not to use it while nursing; LactMed says small occasional doses should not harm a breastfed infant, but larger or longer use may cause drowsiness or lower milk supply. Talk to your prescriber or pharmacist about side effects.
Hydroxyzine is a piperazine H1 antihistamine, chemically unrelated to phenothiazines or benzodiazepines; the label attributes its anxiolytic action to suppression of activity in key subcortical regions and notes antihistaminic, antiemetic, bronchodilator and mild antisecretory effects. It is rapidly absorbed orally, with clinical effects usually within 15 to 30 minutes. Labeled indications for manufactured hydroxyzine hydrochloride tablets: anxiety and tension associated with psychoneurosis or organic disease, pruritus from allergic conditions including chronic urticaria and atopic and contact dermatoses, and premedication or post-anesthesia sedation, where it may potentiate meperidine and barbiturates. The label notes efficacy beyond four months of anxiolytic use has not been systematically assessed. Reduce doses of concomitant CNS depressants. Use caution with congenital or familial long QT, recent myocardial infarction, uncompensated heart failure, bradyarrhythmias, electrolyte imbalance and QT-prolonging drugs. The extent of renal excretion has not been determined, so take care in older adults. Avoid cetirizine and levocetirizine after AGEP or hypersensitivity to hydroxyzine. LiverTox reports no link to clinically apparent liver injury. Dosing is per prescriber. Hydroxyzine is not a controlled substance.
Wash your hands. If the suppository is soft, chill it in its wrapper in the refrigerator or under cool water for a few minutes, then unwrap it. For rectal use, coat the tip with a water-soluble lubricant (not petroleum jelly), lie on your side with your upper knee bent, and insert it pointed end first past the muscle at the opening. For vaginal use, lie on your back with knees bent and insert it as far as it comfortably goes, by finger or applicator; bedtime use limits leakage, and a panty liner protects clothing. Stay lying down about 15 minutes. Wash your hands.
Suppositories are nonaqueous, so under USP <795> they can carry a beyond-use date of up to 180 days at controlled room temperature or in the refrigerator when no other stability data apply. Storage depends on the base: fatty bases can soften at room temperature and may be labeled for the refrigerator, while polyethylene glycol bases usually do not need refrigeration. Keep them cool so they do not melt, and refrigerate them if your label says to.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository